| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
99 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
36 |
| Net Income (TTM) (Millions $) |
-68 |
| Cash Flow (TTM) (Millions $) |
-8 |
| Capital Exp. (TTM) (Millions $) |
3 |
Business Description
Rvl Pharmaceuticals Plc is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of various pharmaceutical products. The company focuses on the development of innovative drugs and therapies to address unmet medical needs across various therapeutic areas, including oncology, neuroscience, immunology, and rare diseases.
Rvl Pharmaceuticals Plc has a strong pipeline of drug candidates in various stages of development, and it actively seeks partnerships and collaborations with academic institutions, biotechnology companies, and other pharmaceutical companies to further enhance its research capabilities and expand its product portfolio.
The company is known for its commitment to quality and compliance with regulatory standards. It operates state-of-the-art manufacturing facilities and adheres to rigorous quality control measures to ensure the safety, efficacy, and reliability of its products.
Rvl Pharmaceuticals Plc has a global presence, with operations in multiple countries and a wide distribution network that enables it to reach patients worldwide. It is dedicated to improving patient outcomes and contributing to the overall advancement of healthcare through its innovative pharmaceutical solutions.
Company Address: 400 Crossing Boulevard Bridgewater 8807 NJ
Company Phone Number: 809-1300 Stock Exchange / Ticker: NASDAQ RVLP
|
%
1.99%